1García Donaire JA,Aláczár JM.Ischemic Nephropathy.Detection and Therapeutic Intervention.Kidney Int,2005,68(Suppl 1):131-136.
2Kato H,Hou J,Aram V,et al.Effect s of angiotensin II infusion and inhibition of nitric oxide synt hase on the rat aorta.J Hypertension,1996,28(2):153-158.
4McMurray J,Solomon S,Pieper K,et al.The effect of valsartan,captopril,or both on atherosclerosis of the valsartan in acute myocardial infarction:an analysis of the valsartan in acute myocardial infarction trial(VALIANT).J Am Coll Cardiol,2006,47 (4):726-733.
5Covic A,Gusbeth-Tatomir P.The role of the rennin-angioten -sin-aldosterone system in renal artery stenosis,renovascular hypertension,and ischemic nephropathy:diagnostic imp lications.Prog Cardiovasc Dis,2009,52 (3):204-208.
6Mizutani A,Okajima K,Murakami K,et al.Activation of sensory neurons reduces ischemia/reperfusion-induced acute renal injury in rats.Anesthesiology,2009,110(2):361 -369.
7Baud L,Ardaillou R.Involvement of reactive oxygen species in kidney damage.Br Med Bull,1998,49(3):621-629.
8Kiyomoto H,Bafiq K,Mostofa M,et al.Possible undedying mechanisms responsible for aldosterone and mineralocorticoid -receptor-dependent renal injury.J Pharmacol Sci,2008,108(4):399-405.
9O'Neill H,Lebeck J,Collins PB,et al.Aldosterone mediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitns.Nephrol Dial Transplant,2008,23(5):1546-1555.
10Yoshimoto T,Hirata Y.Aldosterone as a cardiovascular risk hormone.Endocr J,2007,54(3):359-370.
